Skip to main content
Log in

Preparation and characterization of monoclonal antibodies against VP1 protein of foot-and-mouth disease virus O/China99

  • Published:
Virologica Sinica

Abstract

Monoclonal antibodies (McAbs) 1A9 and 9F12 against Foot-and-mouth disease virus (FMDV) serotype O were produced by fusing SP2/0 myeloma cells with splenocyte from the mouse immunized with O/China99. Both McAbs reacted with O/China99 but not with Asia 1, as determined by immunohistochemistry assay. The microneutralization titer of the McAbs 1A9 and 9F12 were 640 and 1 280, respectively. Both McAbs contain kappa light chains, but the McAbs 1A9 and 9F12 were IgG1 and IgM, respectively. In order to define the McAbs binding epitopes, the reactivity of these McAbs against VP1, P20 and P14 were examined using indirect ELISA, the result showed that both McAbs reacted with VP1 and P20. McAbs may be used for further studies of vaccine, diagnostic methods, prophylaxis, etiological and immunological researches on FMDV.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Cheng I C, Liang S M, Tu J, et al. 2006. Study on the porcinophilic foot-and-mouth disease virus I. production and characterization of monoclonal antibody against VP1. J Vet Med Sci, 68: 859–864.

    Article  CAS  PubMed  Google Scholar 

  2. Crowther J R, Faris S, Carpenter Q C, et al. 1993. Identification of a fifth neutralizable site on type O foot-and-mouth disease virus following characterization of single and quintuple monoclonal antibody escape mutants. J Gen Virol, 74: 1547–1553.

    Article  CAS  PubMed  Google Scholar 

  3. Domingo E, Escarmis C, Baranowski E, et al. 2003. Evolution of foot-and-mouth disease virus. Virus Res, 91(1): 47–63.

    Article  CAS  PubMed  Google Scholar 

  4. Harlow E, Lane D. 1988. Monoclonal antibodies. In: Antibodies a Laboratory Manual, New York: Cold Spring Harbor Laboratory Press, p139–244.

    Google Scholar 

  5. Hong T H, Chen S T, Tang T K, et al. 1989. The production of polyclonal and monoclonal antibodies in mice using novel immunization methods. J Immunol Methods, 120: 151–157.

    Article  CAS  PubMed  Google Scholar 

  6. Jackson T, Sharma A, Ghazaleh R A, et al. 1997. Arginine-glycine-aspartic acid-specific binding by foot-and-mouth disease viruses to the purified integrin alpha (v) beta3 in vitro. J Virol, 71: 8357–8361.

    CAS  PubMed  Google Scholar 

  7. Knowles N J, Samuel A R. 2003. Molecular epidemiology of foot-and-mouth disease virus. Virus Res, 91: 65–80.

    Article  CAS  PubMed  Google Scholar 

  8. Mateu M G, Andreu D, Domingo E. 1995. Antibodies raised in a natural host and monoclonal antibodies recognize similar antigenic features of foot-and-mouth disease virus. Virology, 210: 113–124.

    Article  Google Scholar 

  9. Ming Y, Alfonso C, Rachel S B, et al. 2007. Production and characterization of two serotype independent monoclonal antibodies against foot-and-mouth disease virus. Vet Immunol Immunopathol, 115: 126–134.

    Article  Google Scholar 

  10. OIE (World Organization for Animal Health), 2004. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. 5th ed, Paris. World Organization for Animal Health, p 111–128.

    Google Scholar 

  11. Reed L J, Muench H. 1938. A simple method of estimating fifty per cent end-points. Am J Hyg, 27: 493–497.

    Google Scholar 

  12. Tesar M, Berger H G, Marquardt O. 1989. Serological probes for some foot-and-mouth disease virus nonstructural proteins. Virus Genes, 3: 29–44.

    Article  CAS  PubMed  Google Scholar 

  13. Wang J H, Liang C M, Peng J M, et al. 2003. Induction of immunity in swine by purified recombinant VP1 of foot-and-mouth disease virus. Vaccine, 21: 3721–3729.

    Article  CAS  PubMed  Google Scholar 

  14. McCullough K C, Butcher R. 1982. Monoclonal antibodies against foot-and-mouth disease virus 146S and 12S particles. Arch Virol, 74(1): 1–9.

    Article  CAS  PubMed  Google Scholar 

  15. Smitsaart E N, Saiz J C, Yedloutschnig R J, et al. 1990. Detectionof foot-and-mouth disease virus by competitive ELISA using a monoclonal antibody specific for the 12S protein subunit from six of the seven serotypes. Vet Immunol Immunopathol, 26: 251–265.

    Article  CAS  PubMed  Google Scholar 

  16. Samir K R, Tamishraha B. 2008. Development and characterization of monoclonal antibodies against FMD virus type Asia-1 and determination of antigenic variations in the field strains. Vet Immunol Immunopathol, 122: 241–249.

    Article  Google Scholar 

  17. Xie Q C, McCahon D, Crowther J R, et al. 1987. Neutralization of foot-and-mouth disease virus can be mediated through any of at least three separate antigenic sites. J Gen Virol, 68: 1637–1647.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hui-yun Chang.

Additional information

Foundation items: The national high technology research and development program of China 863 (2006AA10A 204); The national science and technology pillar program (2006BAD06A17).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Song, S., Lin, T., Shao, Jj. et al. Preparation and characterization of monoclonal antibodies against VP1 protein of foot-and-mouth disease virus O/China99. Virol. Sin. 24, 566–572 (2009). https://doi.org/10.1007/s12250-009-3061-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12250-009-3061-0

CLC number

Key words

Navigation